Publications by authors named "C Urla"

Background And Aims: Image Defined Risk Factors (IDRFs) assess surgical risk in neuroblastoma (NB) and guide neoadjuvant therapy. Despite chemotherapy IDRFs may persist in 70 % of cases. Several studies have suggested that not all IDRFs hold equal significance and that the presence of an IDRF does not inherently signify unresectability.

View Article and Find Full Text PDF
Article Synopsis
  • Perianal rhabdomyosarcoma (P)RMS is a rare cancer in young children with a generally poor prognosis, and there's limited data on effective treatments.
  • This study reviewed treatment outcomes for 6 children who received surgery and high-dose rate (HDR) brachytherapy since 2009, with the majority achieving successful organ preservation and survival.
  • The findings suggest that combining surgery and HDR brachytherapy is a feasible treatment option that can improve survival rates and maintain organ function in young patients with (P)RMS.
View Article and Find Full Text PDF

Background & Aims: Children with chronic intestinal failure (IF) require a long-term central venous catheter (CVC) for provision of parenteral nutrition. Vascular, mechanical and infectious complications such as central line-associated bloodstream infections (CLABSI) may lead to progressive loss of venous access sites. Handling and management of CVCs therefore play an important role.

View Article and Find Full Text PDF

Solid tumors of the cervicothoracic junction, the posterior mediastinum, or bilateral dorsal thoracic tumors represent a challenge in pediatric surgical oncology. The aim of this study was to evaluate trap-door thoracotomy and clamshell thoracotomy as surgical approaches. A single-center retrospective study of children with solid tumors in these specific localizations was performed.

View Article and Find Full Text PDF

(1) Background: The study aimed to investigate the influence of MRI-defined residual disease on local tumor control after resection of neuroblastic tumors in patients without routine adjuvant radiotherapy. (2) Methods: Patients, who underwent tumor resection between 2009 and 2019 and received a pre- and postoperative MRI, were included in this retrospective single-center study. Measurement of residual disease (RD) was performed using standardized criteria.

View Article and Find Full Text PDF